Videregen Company

Bringing tissue repair to life Videregen is a leader in the development of personalised, regenerative products to replace, repair and restore organs and tissues. We are a clinical-stage regenerative medicine company using our proprietary technology platform to develop a range of personalised regenerative products treating chronic, life-threatening orphan indications. Videregen’s programmes are focused on the

Last Funding Type: Series A
Funding Status: Early Stage Venture
Headquarters: Liverpool, Liverpool, United Kingdom
Founded Date: 2011
Investor Type: Company
Investment Stage: N/A
Total Funding: $4.27
Technology: Regenerative Medicine
Employee Number: 11-50
Number Of Exists: Series A
Estimated Revenue: $10M to $50M
Investors Number: 4
Industry: Risk Mitigation